Docetaxel Provides Oncological Benefits in the Era of New-Generation Androgen Receptor Inhibitors - or Is Three a Crowd?
- Sanmamed, N.
- Gómez-Rivas, J.
- Buchser, D.
- Montijano, M.
- Gómez-Aparicio, M.A.
- Duque-Santana, V.
- Torres, L.
- Zilli, T.
- Ost, P.
- Maldonado, A.
- López-Campos, F.
- Couñago, F.
ISSN: 1938-0682, 1558-7673
Year of publication: 2024
Volume: 22
Issue: 1
Pages: 56-66
Type: Review